Dataset on mice body weights and food intake following treatment with PG545
Safa Kinaneh,
Mohammad Agbaria,
Niroz Abu-Saleh,
Shadi Hamoud
Affiliations
Safa Kinaneh
Department of Physiology, Rappaport Faculty of Medicine, Technion, Haifa, Israel
Mohammad Agbaria
Department of Internal Medicine A, Rambam Health Care Campus, Haifa, Israel
Niroz Abu-Saleh
Lipid Research Laboratory, Rappaport Faculty of Medicine, Technion, Haifa, Israel
Shadi Hamoud
Lipid Research Laboratory, Rappaport Faculty of Medicine, Technion, Haifa, Israel; Department of Internal medicine E, Rambam Health Care Campus and Rappaport Faculty of Medicine, Haifa, Israel; Correspondence to: Department of Internal Medicine E, Rambam Health Care Campus, Haifa, Israel. Fax: +972 4 7771691.
This data article contains analysis of data observed in E0 mice placed on high fat diet, and treated by intraperitoneal injections of either normal saline (control) or the heparanase inhibitor PG545, in two different doses. Mice body weights and food intake were measured weekly and analyzed data are presented in graphs. Data will be of value for further understanding the role of the enzyme heparanase in controlling food intake and body weight. For further interpretations, see please “Heparanase inhibition attenuates atherosclerosis progression and liver steatosis in E0 mice” (Muhammad et al. 2018).
